Results 21 to 30 of about 31,772 (155)
Targeted treatment with somatostatin analogues: widening horizons of clinical practice
Alʹmanah Kliničeskoj Mediciny, 2022 Targeted treatment with somatostatin analogues (SA) in acromegaly and neuroendocrine neoplasms may have some benefits compared to curative treatments, because these agents decrease excessive hormone secretion and exert a tumor-suppressive effect ...
Vyacheslav S. Pronin +3 more
doaj +1 more source
MDCT imaging in malignant carcinoid syndrome [PDF]
Indian Journal of Gastroenterology, 2011 A 65-year-old lady presented with sudden onset of palpitations, headache, perspirations and flushing. Clinical examination revealed tenderness in right lumbar region. Ultrasound abdomen revealed multiple hyperechoic hepatic lesions and a mesenteric mass.
Kamini, Gupta +3 more
openaire +2 more sources
Frontiers in Endocrinology, 2017 Ectopic adrenocorticotropic hormone (ACTH) syndrome is a challenging diagnosis only responsible for approximately 10% of Cushing syndrome cases. It has been associated with a variety of benign and malignant tumors including a carcinoid tumor accompanied ...
Kyoung Jin Kim +5 more
doaj +1 more source
Endocrine Oncology, 2023 Ectopic adrenocorticotrophic hormone (ACTH) secretion (EAS) is a rare cause of ACTH-dependent Cushing’s syndrome (CS), most often caused by a thoracic neuroendocrine tumor (NET).
Stéphanie Larose +3 more
doaj +1 more source
Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review
Comprehensive Psychiatry, 2021 Introduction: Neuroendocrine tumors (NETs) are rare and malignant neoplasms characterized by their potential to produce metabolically active substances with the capacity to bring about clinical syndromes.
Anna La Salvia +8 more
doaj +1 more source
Year in Review 2018 by the Brazilian Gastrointestinal Tumors Group: Neuroendocrine Tumors
Brazilian Journal of Oncology, 2018 Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms with variable prognoses and clinical presentations. Therefore their therapeutic management is challenging, involving a real multidisciplinary approach composed of medical ...
Duilio R. Rocha +2 more
doaj +1 more source
Unicentric castleman disease complicated by paraneoplastic bronchiolitis obliterans and pemphigus
Respiratory Medicine Case Reports, 2018 Bronchiolitis obliterans (BO) and paraneoplastic pemphigus are rare and ominous complications of Castleman disease. Collectively, these processes have been reported as part of paraneoplastic autoimmune multiorgan syndrome (PAMS), and they can occur in ...
Hassan A. Raza, MD. +6 more
doaj +1 more source
Frontiers in Endocrinology, 2019 Multiple endocrine neoplasia type 1 (MEN1) is a rare hereditary tumor syndrome inherited in an autosomal dominant manner and characterized by a predisposition to a multitude of endocrine neoplasms primarily of parathyroid, enteropancreatic, and anterior ...
Crystal D. C. Kamilaris +1 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen +23 more
wiley +1 more source
Management of the hormonal syndrome of neuroendocrine tumors
Archives of Medical Science, 2016 Gastroenteropancreatic neuroendocrine tumors (GEP/NET) are unusual and relatively rare neoplasms that present many clinical challenges. They characteristically synthesize, store and secrete a variety of peptides and neuroamines which can lead to the ...
Paweł Gut +10 more
doaj +1 more source